Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions

NCT02306902 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ranbaxy Laboratories Limited